Bionano genomics regains compliance with nasdaq minimum bid price listing requirement

San diego, jan. 13, 2021 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo), announced today that it has received a letter from the nasdaq listing qualifications staff notifying the company that it has regained compliance with nasdaq's minimum bid price requirement for continued listing on the nasdaq capital market. the letter noted that as for the last 10 consecutive business days, from december 29, 2020 to january 12, 2021, the closing bid price of the company's common stock has been at $1.00 per share or greater, the company has regained compliance with listing rule 5550(a)(2) and the matter is now closed.
BNGO Ratings Summary
BNGO Quant Ranking